Contact Us    855-RIA-PLAN (855-742-7526)

MORF: Morphic Holding Inc Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,535.02
Enterprise Value ($M) 1,350.86
Book Value ($M) 350.17
Book Value / Share 9.47
Price / Book 4.38
NCAV ($M) 347.01
NCAV / Share 9.39
Price / NCAV 4.42

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -0.38
Return on Equity (ROE) -0.63

Liquidity (mrq)
Quick Ratio 10.43
Current Ratio 10.43

Balance Sheet (mrq) ($M)
Current Assets 435.40
Assets 438.56
Liabilities 88.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-01 13D/A Novo Holdings A/S 5.60 0.00
02-16 13G/A Artal International S.C.A. 5.30 -9.21
02-16 13G/A EcoR1 Capital, LLC 9.10 31.79
02-12 13G/A Pfizer Inc 4.10 -49.95
02-12 13G/A Omega Fund V, L.P. 9.40 -1.26
02-11 13G/A Springer Timothy A 15.60 0.68
02-08 13G/A Fmr Llc 15.00 2.11

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2021-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2021-05-17 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1)
2021-04-29 10-Q Quarterly Report – 10-Q
2021-03-01 10-K Annual Report – 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-01-18 33,969 147,335 23.06
2022-01-13 81,974 269,371 30.43

(click for more detail)

(click for list of largest short owners)

Similar Companies
MNPR – Monopar Therapeutics Inc MOLN – Molecular Partners AG
MOR – MorphoSys AG MREO – Mereo BioPharma Group plc
MRKR – Marker Therapeutics Inc


Financial data and stock pages provided by
Fintel.io





2018/07/06
> Back to All Posts